These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23538188)

  • 1. The cost-effectiveness of a novel SIAscopic diagnostic aid for the management of pigmented skin lesions in primary care: a decision-analytic model.
    Wilson EC; Emery JD; Kinmonth AL; Prevost AT; Morris HC; Humphrys E; Hall PN; Burrows N; Bradshaw L; Walls J; Norris P; Johnson M; Walter FM
    Value Health; 2013; 16(2):356-66. PubMed ID: 23538188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for the MoleMate UK Trial: a randomised controlled trial of the MoleMate system in the management of pigmented skin lesions in primary care [ISRCTN 79932379].
    Walter FM; Morris HC; Humphrys E; Hall PN; Kinmonth AL; Prevost AT; Wilson EC; Burrows N; Norris P; Johnson M; Emery J
    BMC Fam Pract; 2010 May; 11():36. PubMed ID: 20459846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial.
    Walter FM; Morris HC; Humphrys E; Hall PN; Prevost AT; Burrows N; Bradshaw L; Wilson EC; Norris P; Walls J; Johnson M; Kinmonth AL; Emery JD
    BMJ; 2012 Jul; 345():e4110. PubMed ID: 22763392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of SIAscopy for pigmented skin lesions encountered in primary care: development and validation of a new diagnostic algorithm.
    Emery JD; Hunter J; Hall PN; Watson AJ; Moncrieff M; Walter FM
    BMC Dermatol; 2010 Sep; 10():9. PubMed ID: 20868511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VivaScope® 1500 and 3000 systems for detecting and monitoring skin lesions: a systematic review and economic evaluation.
    Edwards SJ; Mavranezouli I; Osei-Assibey G; Marceniuk G; Wakefield V; Karner C
    Health Technol Assess; 2016 Jul; 20(58):1-260. PubMed ID: 27483991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years.
    Gordon LG; Brynes J; Baade PD; Neale RE; Whiteman DC; Youl PH; Aitken JF; Janda M
    Value Health; 2017 Apr; 20(4):593-601. PubMed ID: 28408001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Modeling Study of the Cost-Effectiveness of a Risk-Stratified Surveillance Program for Melanoma in the United Kingdom.
    Wilson ECF; Usher-Smith JA; Emery J; Corrie P; Walter FM
    Value Health; 2018 Jun; 21(6):658-668. PubMed ID: 29909870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and economic evaluation of exercise referral schemes in primary care: a short report.
    Campbell F; Holmes M; Everson-Hock E; Davis S; Buckley Woods H; Anokye N; Tappenden P; Kaltenthaler E
    Health Technol Assess; 2015 Jul; 19(60):1-110. PubMed ID: 26222987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk scores to guide referral decisions for people with suspected ovarian cancer in secondary care: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Lang S; Grimm S; Deshpande S; de Kock S; Armstrong N; Joore M; Kleijnen J
    Health Technol Assess; 2018 Aug; 22(44):1-264. PubMed ID: 30165935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cost-Effectiveness of Bimodal Stimulation Compared to Unilateral and Bilateral Cochlear Implant Use in Adults with Bilateral Severe to Profound Deafness.
    Theriou C; Fielden CA; Kitterick PT
    Ear Hear; 2019; 40(6):1425-1436. PubMed ID: 30998548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual screening for malignant melanoma: a cost-effectiveness analysis.
    Losina E; Walensky RP; Geller A; Beddingfield FC; Wolf LL; Gilchrest BA; Freedberg KA
    Arch Dermatol; 2007 Jan; 143(1):21-8. PubMed ID: 17224538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the MoleMate training program for assessment of suspicious pigmented lesions in primary care.
    Wood A; Morris H; Emery J; Hall PN; Cotton S; Prevost AT; Walter FM
    Inform Prim Care; 2008; 16(1):41-50. PubMed ID: 18534076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical effectiveness and cost-effectiveness of exercise referral schemes: a systematic review and economic evaluation.
    Pavey TG; Anokye N; Taylor AH; Trueman P; Moxham T; Fox KR; Hillsdon M; Green C; Campbell JL; Foster C; Mutrie N; Searle J; Taylor RS
    Health Technol Assess; 2011 Dec; 15(44):i-xii, 1-254. PubMed ID: 22182828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost-effectiveness of exercise referral schemes.
    Anokye NK; Trueman P; Green C; Pavey TG; Hillsdon M; Taylor RS
    BMC Public Health; 2011 Dec; 11():954. PubMed ID: 22200193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of a national exercise referral programme for primary care patients in Wales: results of a randomised controlled trial.
    Edwards RT; Linck P; Hounsome N; Raisanen L; Williams N; Moore L; Murphy S
    BMC Public Health; 2013 Oct; 13():1021. PubMed ID: 24164697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of sorafenib for second-line treatment of advanced renal cell carcinoma.
    Hoyle M; Green C; Thompson-Coon J; Liu Z; Welch K; Moxham T; Stein K
    Value Health; 2010; 13(1):55-60. PubMed ID: 19804431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of insulin pumps compared with multiple daily injections both provided with structured education for adults with type 1 diabetes: a health economic analysis of the Relative Effectiveness of Pumps over Structured Education (REPOSE) randomised controlled trial.
    Pollard DJ; Brennan A; Dixon S; Waugh N; Elliott J; Heller S; Lee E; Campbell M; Basarir H; White D;
    BMJ Open; 2018 Apr; 8(4):e016766. PubMed ID: 29627802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model-based evaluation of the long-term cost-effectiveness of systematic case-finding for COPD in primary care.
    Lambe T; Adab P; Jordan RE; Sitch A; Enocson A; Jolly K; Marsh J; Riley R; Miller M; Cooper BG; Turner AM; Ayres JG; Stockley R; Greenfield S; Siebert S; Daley A; Cheng KK; Fitzmaurice D; Jowett S
    Thorax; 2019 Aug; 74(8):730-739. PubMed ID: 31285359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost Effectiveness of Support for People Starting a New Medication for a Long-Term Condition Through Community Pharmacies: An Economic Evaluation of the New Medicine Service (NMS) Compared with Normal Practice.
    Elliott RA; Tanajewski L; Gkountouras G; Avery AJ; Barber N; Mehta R; Boyd MJ; Latif A; Chuter A; Waring J
    Pharmacoeconomics; 2017 Dec; 35(12):1237-1255. PubMed ID: 28776320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.